Comparison

LY2109761 European Partner

Item no. TMO-T2123-1mg
Manufacturer TargetMol
CASRN 700874-71-1
Amount 1 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 1 mg 200 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,9983
Citations 1. Melisi D, et al. Mol Y Ther, 2008, 7(4), 829-840.
Smiles C(CN1CCOCC1)Oc1ccc2c(ccnc2c1)-c1c2CCCn2nc1-c1ccccn1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias TGF-beta/Smad inhibitor
Shipping Condition Cool pack
Available
Manufacturer - Targets
TGF-beta/Smad|||Autophagy
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
441.52
Description
LY2109761 is a novel selective TGF-β receptor type I/II (TβRI/II) dual inhibitor with Ki of 38 nM and 300 nM, respectively; shown to negatively affect the phosphorylation of Smad2.
Pathways
Autophagy|||Stem Cells
Bioactivity
LY2109761, a new-type, specific TGF-beta receptor type I/II (TbetaRI/II) dual inhibitor( Ki=38 nM and 300 nM), exhibits to negatively affect the phosphorylation of Smad2.
Receptor
TbetaRI; TbetaRII

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close